Yohei Doi, MD, IDWeek chair, Infectious Diseases Society of America, provides some insights on the happenings at this year’s event from Atlanta, Georgia. IDWeek 2025 has commenced, and with it comes ...

Panelists discuss how corticosteroids remain essential for controlling flares but must be used thoughtfully with education and reassurance for families. Panelists discuss how corticosteroids have long ...

Combined or individual use of maternal RSVpreF and infant nirsevimab achieved high antibody levels without safety concerns, supporting current RSV prevention strategies. Maternal RSVpreF vaccination ...

On October 17, 2025, the FDA approved tezepelumab (Tezspire; AstraZeneca and Amgen) as an add-on maintenance treatment for adults and adolescents aged 12 years and older with inadequately controlled ...

In part 3 of this 7-part Special Report, the discussion turns to the importance of diagnostic stewardship, with Denise Heaney, PhD, underscoring how FDA-cleared assays—ranging from at-home sample ...

The clinical report replaces a 2010 report, as food allergy impacts up to 10% of children, with anaphylaxis estimated to occur in 1 in 15 schools per year. Authors note that accurate diagnosis is the ...

Michael Haller, MD, discusses inhaled insulin’s safety, off-label use, and future role in easing type 1 diabetes management for children. Michael Haller, MD, MSCI, professor and chief of pediatric ...

Richard Auchus, MD, PhD, discusses how crinecerfont is improving CAH care and easing the transition from pediatric to adult management. Since its FDA approval on December 13, 2024, crinecerfont ...

The indication approved is for children aged 6 years and older who weigh at least 45 kg (99 lbs) for the preventive treatment of episodic migraine. On August 5, 2025, the FDA approved ...

New CDC data show fewer kindergartners are fully vaccinated as exemption rates increased during the 2024-2025 school year. Vaccination coverage among kindergartners in the United States declined ...

A new polygenic risk score enhances obesity risk prediction from childhood to adulthood, offering new insights for early intervention and prevention strategies. An international team of researchers ...

Pelthos Therapeutics has launched berdazimer (Zelsuvmi) topical gel, 10.3%, for the treatment of molluscum contagiosum in adults and pediatric patients aged 1 year and older, according to a company ...